[Insect Venom Allergies : Update 2016 for Otorhinolaryngologists]

Overview

Journal HNO

Specialty Otorhinolaryngology

Date 2016 Oct 28

PMID 27787580

Authors

L Klimek

N Dippold

A Sperl

Affiliations

Soon will be listed here.

Abstract

Due to the increasing incidence of hymenoptera venom allergies and the potentially life-threatening reactions, it is important for otolaryngologists working in allergology to have an understanding of modern diagnostic and treatment standards for this allergic disease. Molecular diagnosis with recombinant single allergens from bee and wasp venom components improves the diagnostics of insect venom allergies, particularly in patients with double-positive extract-based test results. Detection of specific sensitizations to bee or wasp venom enables double sensitizations to be better distinguished from cross-reactivity. Based on patient history and test results, the patient is initially advised on avoidance strategies and prescribed an emergency medication kit. Then, the indication for allergen-specific immunotherapy (AIT) is evaluated. The dose-increase phase can be performed using conventional, cluster, rush, or ultra-rush schedules, whereby rapid desensitization (rush AIT) performed in the clinic seems to be particularly effective as initial treatment.

References

Franken H, DuBois A, Minkema H, van der Heide S, de Monchy J . Lack of reproducibility of a single negative sting challenge response in the assessment of anaphylactic risk in patients with suspected yellow jacket hypersensitivity. J Allergy Clin Immunol. 1994; 93(2):431-6. DOI: 10.1016/0091-6749(94)90351-4. View

Ewan P, Deighton J, Wilson A, LACHMANN P . Venom-specific IgG antibodies in bee and wasp allergy: lack of correlation with protection from stings. Clin Exp Allergy. 1993; 23(8):647-60. DOI: 10.1111/j.1365-2222.1993.tb01791.x. View

Schumacher M, Tveten M, Egen N . Rate and quantity of delivery of venom from honeybee stings. J Allergy Clin Immunol. 1994; 93(5):831-5. DOI: 10.1016/0091-6749(94)90373-5. View

Vos B, Kohler J, Muller S, Stretz E, Rueff F, Jakob T . Spiking venom with rVes v 5 improves sensitivity of IgE detection in patients with allergy to Vespula venom. J Allergy Clin Immunol. 2012; 131(4):1225-7, 1227.e1. DOI: 10.1016/j.jaci.2012.07.041. View

Hofmann S, Pfender N, Weckesser S, Huss-Marp J, Jakob T . Added value of IgE detection to rApi m 1 and rVes v 5 in patients with Hymenoptera venom allergy. J Allergy Clin Immunol. 2010; 127(1):265-7. DOI: 10.1016/j.jaci.2010.06.042. View

LOVELESS M, FACKLER W . Wasp venom allergy and immunity. 1956. Allergy Proc. 1989; 10(2):157-60. DOI: 10.2500/108854189778961017. View

Schwartz H, Sutheimer C, Gauerke M, Yunginger J . Hymenoptera venom-specific IgE antibodies in post-mortem sera from victims of sudden, unexpected death. Clin Allergy. 1988; 18(5):461-8. DOI: 10.1111/j.1365-2222.1988.tb02896.x. View

Golden D, Langois J, Valentine M, Lichtenstein L . Treatment failures with whole-body extract therapy of insect sting allergy. JAMA. 1981; 246(21):2460-3. View

Kohler J, Blank S, Muller S, Bantleon F, Frick M, Huss-Marp J . Component resolution reveals additional major allergens in patients with honeybee venom allergy. J Allergy Clin Immunol. 2014; 133(5):1383-9, 1389.e1-6. DOI: 10.1016/j.jaci.2013.10.060. View

10.

Urbanek R, Forster J, Kuhn W, Ziupa J . Discontinuation of bee venom immunotherapy in children and adolescents. J Pediatr. 1985; 107(3):367-71. DOI: 10.1016/s0022-3476(85)80508-4. View

11.

Jakob T, Kohler J, Blank S, Magnusson U, Huss-Marp J, Spillner E . Comparable IgE reactivity to natural and recombinant Api m 1 in cross-reactive carbohydrate determinant-negative patients with bee venom allergy. J Allergy Clin Immunol. 2012; 130(1):276-8. DOI: 10.1016/j.jaci.2012.03.048. View

12.

Harries M, Kemeny D, Youlten L, Mills M, Lessof M . Skin and radioallergosorbent tests in patients with sensitivity to bee and wasp venom. Clin Allergy. 1984; 14(5):407-12. DOI: 10.1111/j.1365-2222.1984.tb02223.x. View

13.

Bilo M, Cichocka-Jarosz E, Pumphrey R, Oude-Elberink J, Lange J, Jakob T . Self-medication of anaphylactic reactions due to Hymenoptera stings-an EAACI Task Force Consensus Statement. Allergy. 2016; 71(7):931-43. DOI: 10.1111/all.12908. View

14.

Nataf P, Guinnepain M, Herman D . Rush venom immunotherapy: a 3-day programme for hymenoptera sting allergy. Clin Allergy. 1984; 14(3):269-75. DOI: 10.1111/j.1365-2222.1984.tb02206.x. View

15.

Valentine M, Schuberth K, Graft D, Kwiterovich K, Szklo M, Lichtenstein L . The value of immunotherapy with venom in children with allergy to insect stings. N Engl J Med. 1990; 323(23):1601-3. DOI: 10.1056/NEJM199012063232305. View

16.

REISMAN R, Livingston A . Late-onset allergic reactions, including serum sickness, after insect stings. J Allergy Clin Immunol. 1989; 84(3):331-7. DOI: 10.1016/0091-6749(89)90417-x. View

17.

Berchtold E, Maibach R, Muller U . Reduction of side effects from rush-immunotherapy with honey bee venom by pretreatment with terfenadine. Clin Exp Allergy. 1992; 22(1):59-65. DOI: 10.1111/j.1365-2222.1992.tb00115.x. View

18.

Kampelmacher M, van der Zwan J . Provocation test with a living insect as a diagnostic tool in systemic reactions to bee and wasp venom: a prospective study with emphasis on the clinical aspects. Clin Allergy. 1987; 17(4):317-27. DOI: 10.1111/j.1365-2222.1987.tb02021.x. View

19.

Muller U, Helbling A, Bischof M . Predictive value of venom-specific IgE, IgG and IgG subclass antibodies in patients on immunotherapy with honey bee venom. Allergy. 1989; 44(6):412-8. DOI: 10.1111/j.1398-9995.1989.tb04172.x. View

20.

. Position paper: Immunotherapy with hymenoptera venoms. (EAACI) The European Academy of Allergology and Clinical Immunology. Allergy. 1993; 48(14 Suppl):36-46. View